AzTrials
AzTrials

Airway Management AssessmentATINCT07484841

Comparison of Awake Tracheal Intubation Methods

A study testing Awake tracheal intubation viaFiberoptic Bronchoscopy (ATI:FOB), Awake tracheal Intubation via videolaryngoscopy (ATI:VL) and awake tracheal intubation via aintree catheter loaded FOB through supraglottic airway device (ATI:SAD) in people with Airway Management Assessment and Awake Endotracheal Intubation, run by Kocaeli City Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study was to compare three different awake tracheal intubation technique -fiberoptic bronchoscopy (ATI:FB), videolaryngoscopy (ATI:VL), and fiberoptic bronchoscopy via a supraglottic airway device (ATI:SAD)- in terms of success rates, intubation times, and complications. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Awake tracheal intubation viaFiberoptic Bronchoscopy (ATI:FOB), Awake tracheal Intubation via videolaryngoscopy (ATI:VL) and awake tracheal intubation via aintree catheter loaded FOB through supraglottic airway device (ATI:SAD)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
201 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Mar 2026to 20 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients aged 18 and older
  • Patients classified as ASA I-II according to the American Society of Anesthesiologists (ASA) classification
  • Patients scheduled for elective surgery
  • Patients expected to require difficult mask ventilation, difficult laryngoscopy, or difficult tracheal intubation; patients expected to have short apnea periods (Planjuan goiter); patients at risk of aspiration; patients expected to require difficult rescue techniques; and patients with a reported history of difficult intubation
  • Patients scheduled for intubation using the awake tracheal intubation (ATI) method
  • Individuals who have agreed to participate in the study by signing an informed consent form

Who cannot join

  • Patients with a mouth opening <1.5 cm
  • Patients requiring emergency intubation or emergency surgery (situations where there is insufficient time to administer ATI)
  • Patients who cannot cooperate (mental incapacity, impaired consciousness, inability to communicate, etc.)
  • Patients with known allergies to lidocaine or other local/topical anesthetic agents used
  • Pregnancy
  • Patients with a history of severe cardiac arrhythmia or hemodynamic instability (due to increased risk during intubation)
  • Patients who have previously undergone tracheostomy or whose airway is technically obstructed due to anatomical deformity
  • Patients who refuse to participate in the study or who do not provide informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mehmet Yılmaz, Assoc. Prof. contact

+905052174432

drmyilmaz33@gmail.com

Ayşe Z Turan Cıvraz, Assoc.Prof. contact

05054695850

ayse.zeynep@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Kocaeli City Hospital

    İzmit, Kocaeli, 41060

    Ayşe Turan Cıvraz, Assoc.Prof, 05054695850, ayse.zeynep@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: A Comparison of Three Difficult Intubation Techniques in Patients With Anticipated Difficult Intubation: A Prospective, Randomized, Parallel-group Clinical Trial

The aim of this study was to compare three different awake tracheal intubation technique

-fiberoptic bronchoscopy (ATI:FB), videolaryngoscopy (ATI:VL), and fiberoptic bronchoscopy via a supraglottic airway device (ATI:SAD)- in terms of success rates, intubation times, and complications. Additionally, the study aims to evaluate the reliability of the SAD-assisted ATI method and its potential to contribute to the literature.

Read the detailed description

Awake tracheal intubation (ATI) is a technique considered the gold standard for managing anticipated difficult airways. The success of ATI is based on two key physiological advantages: the preservation of spontaneous breathing and the maintenance of airway tone. Traditionally, ATI is performed using a flexible fiberoptic bronchoscope (ATI:FB). However, in recent years, ATI techniques performed using video laryngoscopy (ATI:VL) have also become widespread and have particularly stood out for their shorter intubation times.

Although randomized studies directly comparing ATI:FB and ATI:VL techniques are limited in the literature, an increasing number of studies are evaluating the comparative efficacy of these techniques. On the other hand, while supraglottic airway devices (SADs) are traditionally used as rescue ventilation devices, current guidelines indicate that they can also serve as a channel for awake intubation in conjunction with fiberoptic bronchoscopy . Various case series and small-scale observational studies exist on this topic. However, there are no prospective studies directly comparing SAD use during ATI with traditional methods such as ATI:FB and ATI:VL. This gap in the literature forms the primary rationale for our study.

The ATI:SAD method currently used in our clinic is a technique in which the Aintree catheter and fiberoptic bronchoscope are utilized via SAD. This method offers advantages such as the ability to continuously monitor spontaneous breathing and maintain uninterrupted oxygenation. In this context, our study aims not only to demonstrate the efficacy of the ATI:SAD method but also to contribute this method to the literature.

Being tested
Awake tracheal intubation viaFiberoptic Bronchoscopy (ATI:FOB), Awake tracheal Intubation via videolaryngoscopy (ATI:VL), awake tracheal intubation via aintree catheter loaded FOB through supraglottic airway device (ATI:SAD)
Keywords
videolaryngoscopy, awake tracheal intubation, fiberoptic bronchoscopy, aintree catheter

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Awake tracheal intubation viaFiberoptic Bronchoscopy (ATI:FOB)Procedure or surgery

    awake tracheal intubation will be perform via FOB

  • Awake tracheal Intubation via videolaryngoscopy (ATI:VL)Procedure or surgery

    Awake tracheal intubation will be perform via videolaryngoscopy

  • awake tracheal intubation via aintree catheter loaded FOB through supraglottic airway device (ATI:SAD)Procedure or surgery

    Awake tracheal Intubation will be perform via aintree catheter loaded FOB through supraglottic airway device

Study groups in NCT07484841
Study groupRoleWhat they receive
Fiberoptic Bronchoscopy (ATI: FOB)Active comparatorIntubation will be perform via fiberoptic bronchoscopy
Receives: Procedure: Awake tracheal intubation viaFiberoptic Bronchoscopy (ATI:FOB)
Videolaryngoscopy (ATI:VL)Active comparatorIntubation will be perform via videolaryngoscopy
Receives: Procedure: Awake tracheal Intubation via videolaryngoscopy (ATI:VL)
Aintree catheter loaded fiberoptic bronchoscopy via Supraglottic Airway Device (ATI:SAD)Active comparatorIntubation will be perform via aintree catheter loaded fiberoptic bronchoscopy through supraglottic airway device
Receives: Procedure: awake tracheal intubation via aintree catheter loaded FOB through supraglottic airway device (ATI:SAD)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate of chosen awake intubation method

    The primary endpoint of the study is the success rate of the selected awake intubation technique, with the intubation method to be chosen via randomization.

    Measured: Through study completion, an average of 2 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2026
  2. Study start20 Mar 2026
  3. Primary completion20 Mar 2028 (estimated)
  4. Study completion20 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
201 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07484841
Sponsor's protocol ID
KŞH-MY-01
Acronym
ATI
Status last verified
Aug 2026
First submitted
13 Mar 2026
Last updated
26 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Awake tracheal intubation viaFiberoptic Bronchoscopy (ATI:FOB), Awake tracheal Intubation via videolaryngoscopy (ATI:VL) and awake tracheal intubation via aintree catheter loaded FOB through supraglottic airway device (ATI:SAD) in people with Airway Management Assessment and Awake Endotracheal Intubation, run by Kocaeli City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mehmet Yılmaz, Assoc. Prof. (+905052174432, drmyilmaz33@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate of chosen awake intubation method (time frame: Through study completion, an average of 2 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in